03:43 PM EST - Knight Therapeutics Inc. : Has extended the first tranche of a fully secured loan of up to $4 Million U.S. to 60° Pharmaceuticals LLC ("60P"). The loan proceeds will allow 60P to continue the development of medicines for treatment and prevention of tropical diseases. In addition, Knight has entered an exclusive license agreement with an option to develop and commercialize all of 60P's products in Canada, Israel and Russia. Knight Therapeutics Inc.
shares T.GUD are trading down $0.05 at $7.45.
